Market Outlook
The US Surgical Heart Valve Devices Market was valued at USD 5.21 billion in 2025 and is projected to reach approximately USD 10.34 billion by 2035, expanding at a CAGR of 7.08% during the forecast period 2026–2035. The historical period spans 2022–2024, with 2025 as the base year.
The market growth trajectory reflects a combination of demographic expansion, increasing valvular heart disease prevalence, structural heart program expansion, and sustained innovation in both surgical and transcatheter valve technologies.
Valvular heart disease (VHD) affects nearly 2.5% of the US population, with aortic stenosis being the most prevalent severe valve disorder among elderly individuals. Approximately 12% of Americans over 75 years exhibit aortic valve stenosis, significantly driving interventional demand.
The US remains the global leader in transcatheter valve innovation, with procedural volumes for TAVR continuing to rise annually. Strong reimbursement frameworks under Medicare and commercial insurers, expanding FDA indications, and robust cardiovascular infrastructure support long-term market stability.
Introduction
The US Surgical Heart Valve Devices Market encompasses implantable prosthetic valves and repair systems used in the treatment of stenotic or regurgitant cardiac valves, including aortic, mitral, tricuspid, and pulmonary valves.
Cardiovascular disease remains the leading cause of mortality in the United States. Structural heart disease, particularly degenerative valve disorders, represents a growing clinical burden due to increasing life expectancy and comorbidity prevalence.
Advanced diagnostic modalities, such as echocardiography, cardiac CT, and MRI, have improved early detection, enabling timely intervention. The US healthcare system’s highly developed cardiac surgery infrastructure, hybrid operating rooms, and structural heart programs support large-scale procedural delivery.
Innovation pipelines, real-world evidence registries, and academic-industry collaboration continue to drive evolution in surgical valve durability and minimally invasive transcatheter therapies.
Key Market Drivers: What’s Fueling the US Surgical Heart Valve Devices Market Growth?
- Aging Population and Rising Disease Incidence
By 2035, adults aged 65 and older will comprise more than 22% of the US population. Degenerative calcific aortic stenosis is highly age-dependent, significantly increasing demand for valve replacement procedures.
Improved survival rates from coronary artery disease and heart failure further contribute to secondary valve dysfunction requiring intervention. - Dominance of Transcatheter Aortic Valve Replacement (TAVR)
TAVR has fundamentally shifted treatment paradigms. Once restricted to high-risk patients, it is now approved for low-risk individuals, dramatically increasing eligible patient pools.
More than 700 US hospitals perform TAVR procedures, and many centers now report TAVR volumes exceeding traditional SAVR. - Technological Innovation and Valve Longevity
Enhanced leaflet durability, anti-calcification tissue processing, repositionable delivery systems, and lower-profile catheter systems have improved safety outcomes and expanded patient eligibility.
Bioprosthetic valves now demonstrate durability extending beyond 15 years in clinical data, increasing adoption among moderately younger populations. - Favorable Reimbursement and Healthcare Infrastructure
CMS reimbursement policies support both SAVR and TAVR procedures under structured DRG payments. Widespread insurance coverage enhances accessibility across regions.
Recent Developments
Recent FDA approvals for expanded TAVR indications and next-generation bioprosthetic valves are strengthening clinical adoption. Structural heart programs are expanding beyond metropolitan areas into mid-sized US cities.
Clinical trials evaluating transcatheter mitral and tricuspid replacements are gaining momentum, indicating future growth potential.
Conclusion
The US Surgical Heart Valve Devices Market Size & Share is positioned for sustained expansion through 2035, supported by demographic trends, reimbursement stability, and continuous innovation in structural heart technologies.
With expanding transcatheter indications, increasing procedural volumes across US states, and a strong competitive ecosystem, the market demonstrates long-term investment attractiveness and clinical significance in improving cardiovascular outcomes nationwide.
Key Market Players
- Edwards Lifesciences
Headquartered in California, Edwards dominates the US TAVR market with strong adoption across structural heart centers. The company continues expanding its SAPIEN valve portfolio and invests heavily in US-based clinical trials. - Medtronic
With extensive US distribution networks, Medtronic provides both surgical and transcatheter valve solutions. The company maintains strong penetration across Midwest and Southern hospital systems. - Abbott Laboratories
Abbott plays a major role in structural heart repair, particularly in mitral and tricuspid interventions, with strong US cardiology partnerships. - Boston Scientific
Expanding its cardiovascular portfolio, Boston Scientific focuses on minimally invasive structural heart solutions within US hospitals. - LivaNova
Provides surgical valve solutions and cardiopulmonary support technologies across US cardiac centers. - Artivion (formerly CryoLife)
US-based company specializing in tissue-based valves and preservation technologies. - Terumo Cardiovascular
Supplies perfusion systems and surgical tools supporting US cardiac surgeries. - Corcym
Provides surgical valve products serving US tertiary hospitals. - Cook Medical
Offers cardiovascular interventional devices used in valve-related procedures. - WL Gore & Associates
Supplies cardiac repair materials and vascular graft solutions. - JenaValve Technology
Advancing transcatheter solutions for aortic regurgitation in US trials. - Colibri Heart Valve
Developing next-generation transcatheter technologies targeting US markets. - Anteris Technologies
Focused on innovative tissue valves undergoing US regulatory evaluation. - Neovasc
Advancing transcatheter mitral technologies in US development programs. - HighLife Medical
Innovative mitral replacement systems under clinical investigation. - Cardiac Dimensions
Specializes in mitral repair technologies with US hospital collaborations. - Foldax
Developing polymer-based mechanical valves targeting reduced anticoagulation dependency. - ValveXchange
Bioengineered valve systems aimed at improving US surgical outcomes. - 4C Medical Technologies
Transcatheter mitral innovations in US clinical evaluation. - Micro Interventional Devices
Develops minimally invasive structural repair devices. - Siemens Healthineers
Provides advanced cardiac imaging systems essential for procedural planning. - GE HealthCare
Strong US presence in interventional imaging and echocardiography solutions. - Philips Healthcare
Supports hybrid operating rooms and structural heart imaging platforms across US hospitals.
- Mechanical Heart Valves
Mechanical valves are primarily used in younger patients requiring lifetime durability. These valves offer longevity exceeding 20 years but require lifelong anticoagulation therapy. Academic cardiac centers in states like New York, Illinois, and California perform a significant portion of mechanical valve procedures. - Bioprosthetic (Tissue) Heart Valves
Bioprosthetic valves dominate surgical valve procedures in the US. These valves eliminate the need for lifelong anticoagulation and are widely used in elderly populations. Continuous improvements in tissue processing technology are expanding their clinical preference. - Transcatheter Heart Valves
Transcatheter valves represent the fastest-growing product segment. TAVR procedures continue to rise due to expanded low-risk approvals and increasing physician experience. Many hospitals in Texas, Florida, and California report year-over-year TAVR growth exceeding 8%. - Sutureless Heart Valves
Sutureless valves reduce operative times and cardiopulmonary bypass duration. They are increasingly used in minimally invasive surgical approaches across tertiary cardiac centers.
- Surgical Aortic Valve Replacement (SAVR)
SAVR remains clinically relevant for complex anatomies and bicuspid valve patients. While TAVR growth is strong, SAVR volumes remain stable in major US centers. - Surgical Mitral Valve Replacement/Repair
Mitral valve repair continues to gain preference due to superior preservation of cardiac function. Advanced imaging and robotic-assisted surgery are supporting improved outcomes. - Transcatheter Aortic Valve Replacement (TAVR)
TAVR continues to expand in both volume and indication. Hospitals in California, Texas, Florida, and New York perform some of the highest TAVR case volumes nationally. - Other Valve Procedures
Tricuspid and pulmonary interventions represent emerging growth areas, with several devices currently in US clinical trials.
- Hospitals
Hospitals account for the largest revenue share due to advanced infrastructure and hybrid operating rooms required for structural heart procedures. - Cardiac Specialty Centers
Specialty cardiac centers serve as regional referral hubs, particularly in metropolitan states. - Ambulatory Surgical Centers (ASCs)
ASCs are gradually entering minimally invasive valve repair segments, although complex valve replacements remain hospital-based.
- Adult Population
Adults represent the dominant segment due to degenerative disease prevalence. - Pediatric Population
Pediatric valve procedures are limited but essential for congenital heart disease management in children’s hospitals across Boston, Philadelphia, Houston, and Los Angeles.
West Region
The West leads in innovation and procedural density.
California dominates regional revenue due to high population, leading cardiac centers, and early TAVR adoption. Los Angeles and San Francisco are major structural heart hubs.
Washington supports strong research-driven programs, while Colorado and Arizona show rising procedural volumes due to expanding healthcare networks.
Oregon, Nevada, Utah, and New Mexico are witnessing gradual expansion of cardiac infrastructure. Alaska and Hawaii maintain limited but stable procedure volumes.
Northeast Region
The Northeast is characterized by academic excellence and high Medicare enrollment.
New York ranks among the highest TAVR-performing states nationally. Massachusetts benefits from world-class cardiac institutions in Boston. Pennsylvania and New Jersey maintain robust procedural volumes.
Connecticut, Rhode Island, Maine, Vermont, and New Hampshire show steady growth driven by hospital modernization.
South Region (Fastest Growing)
The South is the fastest-growing regional segment.
Texas reports one of the highest annual valve replacement volumes nationally due to large population and hospital network expansion.
Florida’s rapidly aging population significantly drives demand.
Georgia and North Carolina are emerging structural heart centers with increasing hybrid OR installations.
Tennessee, South Carolina, Alabama, and Virginia are expanding cardiac specialty programs.
Louisiana, Mississippi, Arkansas, Kentucky, Oklahoma, West Virginia, and Maryland show moderate but improving adoption supported by federal reimbursement frameworks.
Midwest Region
Illinois and Ohio lead the Midwest due to large metropolitan hospitals in Chicago and Cleveland.
Michigan and Minnesota demonstrate strong cardiovascular research programs.
Indiana, Wisconsin, and Missouri continue investing in structural heart labs.
Iowa, Kansas, Nebraska, North Dakota, and South Dakota show steady but lower procedural density due to population distribution.
1. US Surgical Heart Valve Devices Market: Market Introduction & Context
1.1 Market Definition
1.2 Scope of the Study
1.3 Research Methodology
1.3.1 Primary Data Collection
1.3.2 Secondary Data Sourcing
1.3.3 External Industry Collaborations (Cardiac Surgeons, Interventional Cardiologists, Structural Heart Specialists)
1.3.4 In-House Research Databases
1.3.5 Analytical Frameworks & Forecast Modeling
1.3.6 Data Validation and Final Report Publishing
1.4 Key Assumptions
1.5 Market Ecosystem Overview
1.6 Stakeholder Analysis (Manufacturers, Component Suppliers, Hospitals, Cardiac Centers, Distributors, Regulatory Authorities)
What this section provides:
Introduces report scope, research rigor, forecasting methodology, validation process, and market coverage reliability.
2. US Surgical Heart Valve Devices Market: Executive Summary
2.1 Key Insights & Market Snapshot (2025)
2.2 Market Size & CAGR Overview (2025–2035)
2.3 Analyst Viewpoint
2.4 Market Attractiveness Index
2.5 Strategic Growth Highlights
What this section provides:
Concise, decision-maker-ready summary of market size, growth outlook, high-growth segments, and strategic implications.
3. US Surgical Heart Valve Devices Market: Market Dynamics & Outlook
3.1 Market Drivers
3.1.1 Rising Geriatric Population
3.1.2 Increasing Prevalence of Valvular Heart Disease
3.1.3 Expansion of TAVR Indications
3.1.4 Favorable CMS Reimbursement Framework
3.2 Market Restraints
3.2.1 High Procedure Costs
3.2.2 Risk of Device Complications
3.2.3 Skilled Workforce Requirements
3.3 Market Opportunities
3.3.1 Expansion into Community Hospitals
3.3.2 Transcatheter Mitral & Tricuspid Technologies
3.3.3 Pediatric Valve Innovations
3.4 Patent & Innovation Analysis (2020–2025)
What this section provides:
Comprehensive evaluation of growth catalysts, risks, innovation trends, and long-term opportunity mapping.
4. US Surgical Heart Valve Devices Market: Market Environment & Industry Analysis
4.1 PESTEL Analysis
4.1.1 Political
4.1.2 Economic
4.1.3 Social
4.1.4 Technological
4.1.5 Environmental
4.1.6 Legal
4.2 Porter’s Five Forces Analysis
4.2.1 Threat of New Entrants
4.2.2 Bargaining Power of Buyers
4.2.3 Bargaining Power of Suppliers
4.2.4 Substitution Risk
4.2.5 Competitive Rivalry
4.3 Pricing Trend Analysis (2024–2030)
4.4 Value Chain & Supply Chain Analysis
4.5 Regulatory Framework (FDA, CMS)
4.6 Impact of Healthcare Policy Changes
4.7 Impact of Geopolitical & Supply Chain Disruptions
What this section provides:
Strategic overview of industry forces, regulatory landscape, pricing evolution, and competitive intensity.
5. US Surgical Heart Valve Devices Market – By Product Type
5.1 Overview
5.2 Segment Share Analysis, By Product Type, 2025 & 2035 (%)
5.3 Mechanical Heart Valves
5.4 Bioprosthetic (Tissue) Heart Valves
5.5 Transcatheter Heart Valves
5.6 Sutureless Heart Valves
What this section provides:
Revenue breakdown and future growth trajectory by valve technology category.
6. US Surgical Heart Valve Devices Market – By Procedure Type
6.1 Overview
6.2 Segment Share Analysis, By Procedure Type, 2025 & 2035 (%)
6.3 Surgical Aortic Valve Replacement (SAVR)
6.4 Surgical Mitral Valve Replacement/Repair
6.5 Transcatheter Aortic Valve Replacement (TAVR)
6.6 Other Valve Procedures (Tricuspid & Pulmonary)
What this section provides:
Procedure-level revenue trends, volume growth, and technology penetration insights.
7. US Surgical Heart Valve Devices Market – By End User
7.1 Overview
7.2 Segment Share Analysis, By End User, 2025 & 2035 (%)
7.3 Hospitals
7.4 Cardiac Specialty Centers
7.5 Ambulatory Surgical Centers (ASCs)
What this section provides:
Institutional adoption trends and revenue distribution by care delivery settings.
8. US Surgical Heart Valve Devices Market – By Patient Demographics
8.1 Overview
8.2 Segment Share Analysis, By Patient Demographics, 2025 & 2035 (%)
8.3 Adult
8.4 Pediatric
What this section provides:
Patient population-based revenue contribution and demand projections.
9. US Surgical Heart Valve Devices Market – By Geography
9.1 Introduction
9.2 Segment Share Analysis, By Geography, 2025 & 2035 (%)
9.3 West Region
9.3.1 Regional Overview & Trends
9.3.2 West Region Key Manufacturers & Structural Heart Centers
9.3.3 West Region Market Size & Forecast, By State, 2025–2035 (USD Million)
9.3.4 West Region Market Size, By Product Type
9.3.5 West Region Market Size, By Procedure Type
9.3.6 West Region Market Size, By End User
9.3.7 California
9.3.7.1 Overview
9.3.7.2 Market Size & Forecast (2025–2035)
9.3.7.3 By Product Type
9.3.7.4 By Procedure Type
9.3.7.5 By End User
9.3.8 Washington
9.3.9 Colorado
9.3.10 Arizona
9.3.11 Oregon
9.3.12 Others (West Region)
9.3.12.1 Utah
9.3.12.2 Nevada
9.3.12.3 New Mexico
9.3.12.4 Idaho
9.3.12.5 Montana
9.3.12.6 Wyoming
9.3.12.7 Alaska
9.3.12.8 Hawaii
9.4 Northeast Region
9.4.1 Regional Overview & Trends
9.4.2 New York
9.4.3 Massachusetts
9.4.4 New Jersey
9.4.5 Pennsylvania
9.4.6 Connecticut
9.4.7 Others (Northeast Region)
9.4.7.1 Maine
9.4.7.2 Vermont
9.4.7.3 New Hampshire
9.4.7.4 Rhode Island
9.4.7.5 Delaware
9.5 South Region
9.5.1 Regional Overview & Trends
9.5.2 Texas
9.5.3 Florida
9.5.4 Georgia
9.5.5 North Carolina
9.5.6 Tennessee
9.5.7 South Carolina
9.5.8 Alabama
9.5.9 Others (South Region)
9.5.9.1 Mississippi
9.5.9.2 Louisiana
9.5.9.3 Arkansas
9.5.9.4 Kentucky
9.5.9.5 Oklahoma
9.5.9.6 Maryland
9.5.9.7 Virginia
9.5.9.8 West Virginia
9.6 Midwest Region
9.6.1 Regional Overview & Trends
9.6.2 Illinois
9.6.3 Ohio
9.6.4 Michigan
9.6.5 Minnesota
9.6.6 Indiana
9.6.7 Wisconsin
9.6.8 Missouri
9.6.9 Others (Midwest Region)
9.6.9.1 Iowa
9.6.9.2 Kansas
9.6.9.3 Nebraska
9.6.9.4 North Dakota
9.6.9.5 South Dakota
What this section provides:
Comprehensive state-level revenue forecasts, structural heart program density insights, procedural volume trends, and regional growth hotspots across all 50 US states.
10. US Surgical Heart Valve Devices Market: Competitive Landscape & Company Profiles
10.1 Market Share Analysis (2025)
10.2 Company Positioning Matrix
10.3 Company Profiles
10.3.1 Edwards Lifesciences
10.3.2 Medtronic
10.3.3 Abbott Laboratories
10.3.4 Boston Scientific
10.3.5 LivaNova
10.3.6 Artivion
10.3.7 Terumo Cardiovascular
10.3.8 Corcym
10.3.9 Cook Medical
10.3.10 WL Gore & Associates
10.3.11 JenaValve Technology
10.3.12 Colibri Heart Valve
10.3.13 Anteris Technologies
10.3.14 Neovasc
10.3.15 HighLife Medical
10.3.16 Cardiac Dimensions
10.3.17 Foldax
10.3.18 ValveXchange
10.3.19 4C Medical Technologies
10.3.20 Micro Interventional Devices
10.3.21 Siemens Healthineers
10.3.22 GE HealthCare
10.3.23 Philips Healthcare
Note: Each profile includes Overview, Product Portfolio, US Strategy, Financial Snapshot, and Recent Developments.
What this section provides:
Competitive benchmarking, strategic positioning, innovation pipelines, and partnership analysis.
11. US Surgical Heart Valve Devices Market: Future Market Outlook (2026–2035)
11.1 Scenario Analysis (Optimistic, Realistic, Conservative)
11.2 Impact of Next-Generation Valve Technologies
11.3 Structural Heart Expansion into Community Hospitals
11.4 Emerging Trends in Minimally Invasive Cardiac Surgery
What this section provides:
Forward-looking projections, risk-adjusted scenarios, and disruption outlook.
12. US Surgical Heart Valve Devices Market: Strategic Recommendations
12.1 For Manufacturers
12.2 For Hospitals & Health Systems
12.3 For Investors
12.4 For New Entrants
What this section provides:
Actionable strategic insights to maximize growth and mitigate risk.
13. Disclaimer
What this section provides:
Legal boundaries, usage limitations, and report liability clarification.
List of Tables
TABLE 1: List of Data Sources
TABLE 2: Market Drivers; Impact Analysis
TABLE 3: Market Restraints; Impact Analysis
TABLE 4: US Surgical Heart Valve Devices Market: Product Type Snapshot (2025)
TABLE 5: Segment Dashboard; Definition and Scope, by Product Type
TABLE 6: US Surgical Heart Valve Devices Market, by Product Type, 2022–2035 (USD Million)
TABLE 7: US Surgical Heart Valve Devices Market: Procedure Type Snapshot (2025)
TABLE 8: Segment Dashboard; Definition and Scope, by Procedure Type
TABLE 9: US Surgical Heart Valve Devices Market, by Procedure Type, 2022–2035 (USD Million)
TABLE 10: US Surgical Heart Valve Devices Market: End User Snapshot (2025)
TABLE 11: Segment Dashboard; Definition and Scope, by End User
TABLE 12: US Surgical Heart Valve Devices Market, by End User, 2022–2035 (USD Million)
TABLE 13: US Surgical Heart Valve Devices Market: Patient Demographics Snapshot (2025)
TABLE 14: Segment Dashboard; Definition and Scope, by Patient Demographics
TABLE 15: US Surgical Heart Valve Devices Market, by Patient Demographics, 2022–2035 (USD Million)
TABLE 16: US Surgical Heart Valve Devices Market: Regional Snapshot (2025)
TABLE 17: Segment Dashboard; Definition and Scope, by Region
TABLE 18: US Surgical Heart Valve Devices Market, by Region, 2022–2035 (USD Million)
TABLE 19: California Surgical Heart Valve Devices Market, by Product Type, 2022–2035 (USD Million)
TABLE 20: California Surgical Heart Valve Devices Market, by Procedure Type, 2022–2035 (USD Million)
TABLE 21: California Surgical Heart Valve Devices Market, by End User, 2022–2035 (USD Million)
TABLE 22: California Surgical Heart Valve Devices Market, by Patient Demographics, 2022–2035 (USD Million)
TABLE 23: Washington Surgical Heart Valve Devices Market, by Product Type, 2022–2035 (USD Million)
TABLE 24: Washington Surgical Heart Valve Devices Market, by Procedure Type, 2022–2035 (USD Million)
TABLE 25: Washington Surgical Heart Valve Devices Market, by End User, 2022–2035 (USD Million)
TABLE 26: Washington Surgical Heart Valve Devices Market, by Patient Demographics, 2022–2035 (USD Million)
TABLE 27: Colorado Surgical Heart Valve Devices Market, by Product Type, 2022–2035 (USD Million)
TABLE 28: Colorado Surgical Heart Valve Devices Market, by Procedure Type, 2022–2035 (USD Million)
TABLE 29: Colorado Surgical Heart Valve Devices Market, by End User, 2022–2035 (USD Million)
TABLE 30: Colorado Surgical Heart Valve Devices Market, by Patient Demographics, 2022–2035 (USD Million)
TABLE 31: Arizona Surgical Heart Valve Devices Market, by Product Type, 2022–2035 (USD Million)
TABLE 32: Arizona Surgical Heart Valve Devices Market, by Procedure Type, 2022–2035 (USD Million)
TABLE 33: Arizona Surgical Heart Valve Devices Market, by End User, 2022–2035 (USD Million)
TABLE 34: Arizona Surgical Heart Valve Devices Market, by Patient Demographics, 2022–2035 (USD Million)
TABLE 35: Oregon Surgical Heart Valve Devices Market, by Product Type, 2022–2035 (USD Million)
TABLE 36: Oregon Surgical Heart Valve Devices Market, by Procedure Type, 2022–2035 (USD Million)
TABLE 37: Oregon Surgical Heart Valve Devices Market, by End User, 2022–2035 (USD Million)
TABLE 38: Oregon Surgical Heart Valve Devices Market, by Patient Demographics, 2022–2035 (USD Million)
TABLE 39: West – Others Surgical Heart Valve Devices Market, by Product Type, 2022–2035 (USD Million)
TABLE 40: West – Others Surgical Heart Valve Devices Market, by Procedure Type, 2022–2035 (USD Million)
TABLE 41: West – Others Surgical Heart Valve Devices Market, by End User, 2022–2035 (USD Million)
TABLE 42: West – Others Surgical Heart Valve Devices Market, by Patient Demographics, 2022–2035 (USD Million)
(Nevada, Utah, New Mexico, Idaho, Montana, Wyoming, Alaska, Hawaii)
TABLE 43: New York Surgical Heart Valve Devices Market, by Product Type, 2022–2035 (USD Million)
TABLE 44: New York Surgical Heart Valve Devices Market, by Procedure Type, 2022–2035 (USD Million)
TABLE 45: New York Surgical Heart Valve Devices Market, by End User, 2022–2035 (USD Million)
TABLE 46: New York Surgical Heart Valve Devices Market, by Patient Demographics, 2022–2035 (USD Million)
TABLE 47: Massachusetts Surgical Heart Valve Devices Market, by Product Type, 2022–2035 (USD Million)
TABLE 48: Massachusetts Surgical Heart Valve Devices Market, by Procedure Type, 2022–2035 (USD Million)
TABLE 49: Massachusetts Surgical Heart Valve Devices Market, by End User, 2022–2035 (USD Million)
TABLE 50: Massachusetts Surgical Heart Valve Devices Market, by Patient Demographics, 2022–2035 (USD Million)
TABLE 51: New Jersey Surgical Heart Valve Devices Market, by Product Type, 2022–2035 (USD Million)
TABLE 52: New Jersey Surgical Heart Valve Devices Market, by Procedure Type, 2022–2035 (USD Million)
TABLE 53: New Jersey Surgical Heart Valve Devices Market, by End User, 2022–2035 (USD Million)
TABLE 54: New Jersey Surgical Heart Valve Devices Market, by Patient Demographics, 2022–2035 (USD Million)
TABLE 55: Pennsylvania Surgical Heart Valve Devices Market, by Product Type, 2022–2035 (USD Million)
TABLE 56: Pennsylvania Surgical Heart Valve Devices Market, by Procedure Type, 2022–2035 (USD Million)
TABLE 57: Pennsylvania Surgical Heart Valve Devices Market, by End User, 2022–2035 (USD Million)
TABLE 58: Pennsylvania Surgical Heart Valve Devices Market, by Patient Demographics, 2022–2035 (USD Million)
TABLE 59: Connecticut Surgical Heart Valve Devices Market, by Product Type, 2022–2035 (USD Million)
TABLE 60: Connecticut Surgical Heart Valve Devices Market, by Procedure Type, 2022–2035 (USD Million)
TABLE 61: Connecticut Surgical Heart Valve Devices Market, by End User, 2022–2035 (USD Million)
TABLE 62: Connecticut Surgical Heart Valve Devices Market, by Patient Demographics, 2022–2035 (USD Million)
TABLE 63: Northeast – Others Surgical Heart Valve Devices Market, by Product Type, 2022–2035 (USD Million)
TABLE 64: Northeast – Others Surgical Heart Valve Devices Market, by Procedure Type, 2022–2035 (USD Million)
TABLE 65: Northeast – Others Surgical Heart Valve Devices Market, by End User, 2022–2035 (USD Million)
TABLE 66: Northeast – Others Surgical Heart Valve Devices Market, by Patient Demographics, 2022–2035 (USD Million)
(Maine, Vermont, New Hampshire, Rhode Island, Delaware)
TABLE 67: Texas Surgical Heart Valve Devices Market, by Product Type, 2022–2035 (USD Million)
TABLE 68: Texas Surgical Heart Valve Devices Market, by Procedure Type, 2022–2035 (USD Million)
TABLE 69: Texas Surgical Heart Valve Devices Market, by End User, 2022–2035 (USD Million)
TABLE 70: Texas Surgical Heart Valve Devices Market, by Patient Demographics, 2022–2035 (USD Million)
TABLE 71: Florida Surgical Heart Valve Devices Market, by Product Type, 2022–2035 (USD Million)
TABLE 72: Florida Surgical Heart Valve Devices Market, by Procedure Type, 2022–2035 (USD Million)
TABLE 73: Florida Surgical Heart Valve Devices Market, by End User, 2022–2035 (USD Million)
TABLE 74: Florida Surgical Heart Valve Devices Market, by Patient Demographics, 2022–2035 (USD Million)
TABLE 75: Georgia Surgical Heart Valve Devices Market, by Product Type, 2022–2035 (USD Million)
TABLE 76: Georgia Surgical Heart Valve Devices Market, by Procedure Type, 2022–2035 (USD Million)
TABLE 77: Georgia Surgical Heart Valve Devices Market, by End User, 2022–2035 (USD Million)
TABLE 78: Georgia Surgical Heart Valve Devices Market, by Patient Demographics, 2022–2035 (USD Million)
TABLE 79: North Carolina Surgical Heart Valve Devices Market, by Product Type, 2022–2035 (USD Million)
TABLE 80: North Carolina Surgical Heart Valve Devices Market, by Procedure Type, 2022–2035 (USD Million)
TABLE 81: North Carolina Surgical Heart Valve Devices Market, by End User, 2022–2035 (USD Million)
TABLE 82: North Carolina Surgical Heart Valve Devices Market, by Patient Demographics, 2022–2035 (USD Million)
TABLE 83: Tennessee Surgical Heart Valve Devices Market, by Product Type, 2022–2035 (USD Million)
TABLE 84: Tennessee Surgical Heart Valve Devices Market, by Procedure Type, 2022–2035 (USD Million)
TABLE 85: Tennessee Surgical Heart Valve Devices Market, by End User, 2022–2035 (USD Million)
TABLE 86: Tennessee Surgical Heart Valve Devices Market, by Patient Demographics, 2022–2035 (USD Million)
TABLE 87: South Carolina Surgical Heart Valve Devices Market, by Product Type, 2022–2035 (USD Million)
TABLE 88: South Carolina Surgical Heart Valve Devices Market, by Procedure Type, 2022–2035 (USD Million)
TABLE 89: South Carolina Surgical Heart Valve Devices Market, by End User, 2022–2035 (USD Million)
TABLE 90: South Carolina Surgical Heart Valve Devices Market, by Patient Demographics, 2022–2035 (USD Million)
TABLE 91: Alabama Surgical Heart Valve Devices Market, by Product Type, 2022–2035 (USD Million)
TABLE 92: Alabama Surgical Heart Valve Devices Market, by Procedure Type, 2022–2035 (USD Million)
TABLE 93: Alabama Surgical Heart Valve Devices Market, by End User, 2022–2035 (USD Million)
TABLE 94: Alabama Surgical Heart Valve Devices Market, by Patient Demographics, 2022–2035 (USD Million)
TABLE 95: South – Others Surgical Heart Valve Devices Market, by Product Type, 2022–2035 (USD Million)
TABLE 96: South – Others Surgical Heart Valve Devices Market, by Procedure Type, 2022–2035 (USD Million)
TABLE 97: South – Others Surgical Heart Valve Devices Market, by End User, 2022–2035 (USD Million)
TABLE 98: South – Others Surgical Heart Valve Devices Market, by Patient Demographics, 2022–2035 (USD Million)
(Mississippi, Louisiana, Arkansas, Kentucky, Oklahoma, Virginia, Maryland, West Virginia)
TABLE 99: Illinois Surgical Heart Valve Devices Market, by Product Type, 2022–2035 (USD Million)
TABLE 100: Illinois Surgical Heart Valve Devices Market, by Procedure Type, 2022–2035 (USD Million)
TABLE 101: Illinois Surgical Heart Valve Devices Market, by End User, 2022–2035 (USD Million)
TABLE 102: Illinois Surgical Heart Valve Devices Market, by Patient Demographics, 2022–2035 (USD Million)
TABLE 103: Ohio Surgical Heart Valve Devices Market, by Product Type, 2022–2035 (USD Million)
TABLE 104: Ohio Surgical Heart Valve Devices Market, by Procedure Type, 2022–2035 (USD Million)
TABLE 105: Ohio Surgical Heart Valve Devices Market, by End User, 2022–2035 (USD Million)
TABLE 106: Ohio Surgical Heart Valve Devices Market, by Patient Demographics, 2022–2035 (USD Million)
TABLE 107: Michigan Surgical Heart Valve Devices Market, by Product Type, 2022–2035 (USD Million)
TABLE 108: Michigan Surgical Heart Valve Devices Market, by Procedure Type, 2022–2035 (USD Million)
TABLE 109: Michigan Surgical Heart Valve Devices Market, by End User, 2022–2035 (USD Million)
TABLE 110: Michigan Surgical Heart Valve Devices Market, by Patient Demographics, 2022–2035 (USD Million)
TABLE 111: Minnesota Surgical Heart Valve Devices Market, by Product Type, 2022–2035 (USD Million)
TABLE 112: Minnesota Surgical Heart Valve Devices Market, by Procedure Type, 2022–2035 (USD Million)
TABLE 113: Minnesota Surgical Heart Valve Devices Market, by End User, 2022–2035 (USD Million)
TABLE 114: Minnesota Surgical Heart Valve Devices Market, by Patient Demographics, 2022–2035 (USD Million)
TABLE 115: Indiana Surgical Heart Valve Devices Market, by Product Type, 2022–2035 (USD Million)
TABLE 116: Indiana Surgical Heart Valve Devices Market, by Procedure Type, 2022–2035 (USD Million)
TABLE 117: Indiana Surgical Heart Valve Devices Market, by End User, 2022–2035 (USD Million)
TABLE 118: Indiana Surgical Heart Valve Devices Market, by Patient Demographics, 2022–2035 (USD Million)
TABLE 119: Wisconsin Surgical Heart Valve Devices Market, by Product Type, 2022–2035 (USD Million)
TABLE 120: Wisconsin Surgical Heart Valve Devices Market, by Procedure Type, 2022–2035 (USD Million)
TABLE 121: Wisconsin Surgical Heart Valve Devices Market, by End User, 2022–2035 (USD Million)
TABLE 122: Wisconsin Surgical Heart Valve Devices Market, by Patient Demographics, 2022–2035 (USD Million)
TABLE 123: Missouri Surgical Heart Valve Devices Market, by Product Type, 2022–2035 (USD Million)
TABLE 124: Missouri Surgical Heart Valve Devices Market, by Procedure Type, 2022–2035 (USD Million)
TABLE 125: Missouri Surgical Heart Valve Devices Market, by End User, 2022–2035 (USD Million)
TABLE 126: Missouri Surgical Heart Valve Devices Market, by Patient Demographics, 2022–2035 (USD Million)
TABLE 127: Midwest – Others Surgical Heart Valve Devices Market, by Product Type, 2022–2035 (USD Million)
TABLE 128: Midwest – Others Surgical Heart Valve Devices Market, by Procedure Type, 2022–2035 (USD Million)
TABLE 129: Midwest – Others Surgical Heart Valve Devices Market, by End User, 2022–2035 (USD Million)
TABLE 130: Midwest – Others Surgical Heart Valve Devices Market, by Patient Demographics, 2022–2035 (USD Million)
(Iowa, Kansas, Nebraska, North Dakota, South Dakota)
List of Figures
FIGURE 1: US Surgical Heart Valve Devices Market Segmentation
FIGURE 2: Market Research Methodology
FIGURE 3: Value Chain Analysis
FIGURE 4: PESTEL Analysis
FIGURE 5: Porter’s Five Forces Analysis
FIGURE 6: Market Attractiveness Analysis
FIGURE 7: Market Dynamics
FIGURE 8: Innovation & Patent Landscape (2020–2025)
FIGURE 9: Competitive Landscape; Key Company Market Share Analysis, 2025
FIGURE 10: Product Type Segment Market Share Analysis, 2025 & 2035
FIGURE 11: Product Type Segment Market Size Forecast and Trend Analysis, 2026–2035 (USD Million)
FIGURE 12: Procedure Type Segment Market Share Analysis, 2025 & 2035
FIGURE 13: Procedure Type Segment Market Size Forecast and Trend Analysis, 2026–2035 (USD Million)
FIGURE 14: End User Segment Market Share Analysis, 2025 & 2035
FIGURE 15: End User Segment Market Size Forecast and Trend Analysis, 2026–2035 (USD Million)
FIGURE 16: Patient Demographics Segment Market Share Analysis, 2025 & 2035
FIGURE 17: Patient Demographics Segment Market Size Forecast and Trend Analysis, 2026–2035 (USD Million)
FIGURE 18: Regional Segment Market Share Analysis, 2025 & 2035
FIGURE 19: Regional Segment Market Size Forecast and Trend Analysis, 2026–2035 (USD Million)
FIGURE 20: West Region US Surgical Heart Valve Devices Market Share and Leading Players, 2025
FIGURE 21: Northeast Region US Surgical Heart Valve Devices Market Share and Leading Players, 2025
FIGURE 22: South Region US Surgical Heart Valve Devices Market Share and Leading Players, 2025
FIGURE 23: Midwest Region US Surgical Heart Valve Devices Market Share and Leading Players, 2025
FIGURE 24: West Region Market Share Analysis by State, 2025
FIGURE 25: California Surgical Heart Valve Devices Market Size, Forecast and Trend Analysis, 2026–2035 (USD Million)
FIGURE 26: Washington Surgical Heart Valve Devices Market Size, Forecast and Trend Analysis, 2026–2035 (USD Million)
FIGURE 27: Colorado Surgical Heart Valve Devices Market Size, Forecast and Trend Analysis, 2026–2035 (USD Million)
FIGURE 28: Arizona Surgical Heart Valve Devices Market Size, Forecast and Trend Analysis, 2026–2035 (USD Million)
FIGURE 29: Oregon Surgical Heart Valve Devices Market Size, Forecast and Trend Analysis, 2026–2035 (USD Million)
FIGURE 30: Others (West Region) Surgical Heart Valve Devices Market Size, Forecast and Trend Analysis, 2026–2035 (USD Million)
FIGURE 31: South Region Market Share Analysis by State, 2025
FIGURE 32: Texas Surgical Heart Valve Devices Market Size, Forecast and Trend Analysis, 2026–2035 (USD Million)
FIGURE 33: Florida Surgical Heart Valve Devices Market Size, Forecast and Trend Analysis, 2026–2035 (USD Million)
FIGURE 34: Georgia Surgical Heart Valve Devices Market Size, Forecast and Trend Analysis, 2026–2035 (USD Million)
FIGURE 35: North Carolina Surgical Heart Valve Devices Market Size, Forecast and Trend Analysis, 2026–2035 (USD Million)
FIGURE 36: Tennessee Surgical Heart Valve Devices Market Size, Forecast and Trend Analysis, 2026–2035 (USD Million)
FIGURE 37: South Carolina Surgical Heart Valve Devices Market Size, Forecast and Trend Analysis, 2026–2035 (USD Million)
FIGURE 38: Alabama Surgical Heart Valve Devices Market Size, Forecast and Trend Analysis, 2026–2035 (USD Million)
FIGURE 39: Others (South Region) Surgical Heart Valve Devices Market Size, Forecast and Trend Analysis, 2026–2035 (USD Million)
FIGURE 40: Midwest Region Market Share Analysis by State, 2025
FIGURE 41: Illinois Surgical Heart Valve Devices Market Size, Forecast and Trend Analysis, 2026–2035 (USD Million)
FIGURE 42: Ohio Surgical Heart Valve Devices Market Size, Forecast and Trend Analysis, 2026–2035 (USD Million)
FIGURE 43: Michigan Surgical Heart Valve Devices Market Size, Forecast and Trend Analysis, 2026–2035 (USD Million)
FIGURE 44: Minnesota Surgical Heart Valve Devices Market Size, Forecast and Trend Analysis, 2026–2035 (USD Million)
FIGURE 45: Indiana Surgical Heart Valve Devices Market Size, Forecast and Trend Analysis, 2026–2035 (USD Million)
FIGURE 46: Wisconsin Surgical Heart Valve Devices Market Size, Forecast and Trend Analysis, 2026–2035 (USD Million)
FIGURE 47: Missouri Surgical Heart Valve Devices Market Size, Forecast and Trend Analysis, 2026–2035 (USD Million)
FIGURE 48: Others (Midwest Region) Surgical Heart Valve Devices Market Size, Forecast and Trend Analysis, 2026–2035 (USD Million)
FIGURE 49: Northeast Region Market Share Analysis by State, 2025
FIGURE 50: New York Surgical Heart Valve Devices Market Size, Forecast and Trend Analysis, 2026–2035 (USD Million)
FIGURE 51: Massachusetts Surgical Heart Valve Devices Market Size, Forecast and Trend Analysis, 2026–2035 (USD Million)
FIGURE 52: New Jersey Surgical Heart Valve Devices Market Size, Forecast and Trend Analysis, 2026–2035 (USD Million)
FIGURE 53: Pennsylvania Surgical Heart Valve Devices Market Size, Forecast and Trend Analysis, 2026–2035 (USD Million)
FIGURE 54: Connecticut Surgical Heart Valve Devices Market Size, Forecast and Trend Analysis, 2026–2035 (USD Million)
FIGURE 55: Others (Northeast Region) Surgical Heart Valve Devices Market Size, Forecast and Trend Analysis, 2026–2035 (USD Million)
